378 related articles for article (PubMed ID: 23587667)
21. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation.
Liu SX; Hou FF; Guo ZJ; Nagai R; Zhang WR; Liu ZQ; Zhou ZM; Zhou M; Xie D; Wang GB; Zhang X
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1156-62. PubMed ID: 16497990
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end products and endothelial dysfunction in type 2 diabetes.
Tan KC; Chow WS; Ai VH; Metz C; Bucala R; Lam KS
Diabetes Care; 2002 Jun; 25(6):1055-9. PubMed ID: 12032114
[TBL] [Abstract][Full Text] [Related]
23. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress markers are increased in patients with mastocytosis.
Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
[TBL] [Abstract][Full Text] [Related]
25. Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases.
Rasool M; Malik A; Butt TT; Ashraf MAB; Rasool R; Zahid A; Waquar S; Asif M; Zaheer A; Jabbar A; Zain M; Mehmood A; Qaisrani TB; Malik IR; Khan SU; Mirza Z; Haque A; Al-Qahtani MH; Karim S
Saudi J Biol Sci; 2019 Feb; 26(2):334-339. PubMed ID: 31485173
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus.
Dullaart RP; Annema W; de Boer JF; Tietge UJ
Atherosclerosis; 2012 Jun; 222(2):567-73. PubMed ID: 22541874
[TBL] [Abstract][Full Text] [Related]
27. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications.
Vaishnav MS; Kumari N; Srikanta S; Simha V; Krishnaswamy PR; Balaram P; Bhat N
Metab Syndr Relat Disord; 2024 Jun; 22(5):372-384. PubMed ID: 38696648
[No Abstract] [Full Text] [Related]
28. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.
Kellow NJ; Coughlan MT; Savige GS; Reid CM
BMC Endocr Disord; 2014 Jul; 14():55. PubMed ID: 25011647
[TBL] [Abstract][Full Text] [Related]
29. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions.
Gangemi S; Allegra A; Alonci A; Cristani M; Russo S; Speciale A; Penna G; Spatari G; Cannavò A; Bellomo G; Musolino C
Inflamm Res; 2012 Oct; 61(10):1063-7. PubMed ID: 22674324
[TBL] [Abstract][Full Text] [Related]
30. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
Venturini D; Simão AN; Dichi I
Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193
[TBL] [Abstract][Full Text] [Related]
31. Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects.
Saisho Y; Maruyama T; Hirose H; Saruta T
Diabetes Res Clin Pract; 2007 Nov; 78(2):182-8. PubMed ID: 17467843
[TBL] [Abstract][Full Text] [Related]
32. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
[TBL] [Abstract][Full Text] [Related]
33. Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus.
Mulder DJ; de Boer JF; Graaff R; de Vries R; Annema W; Lefrandt JD; Smit AJ; Tietge UJ; Dullaart RP
Atherosclerosis; 2011 Sep; 218(1):102-6. PubMed ID: 21665206
[TBL] [Abstract][Full Text] [Related]
34. Differential Spectrum of Albumin Glycation, Oxidation, and Truncation in Type 2 and Type 1 Diabetes: Clinical and Biological Implications.
Vaishnav MS; Kumari N; Srikanta S; Krishnaswamy PR; Balaram P; Bhat N
Metab Syndr Relat Disord; 2023 Sep; 21(7):397-409. PubMed ID: 37471231
[No Abstract] [Full Text] [Related]
35. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
[TBL] [Abstract][Full Text] [Related]
36. Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes.
Chiu CJ; Rabbani N; Rowan S; Chang ML; Sawyer S; Hu FB; Willett W; Thornalley PJ; Anwar A; Bar L; Kang JH; Taylor A
Biofactors; 2018 May; 44(3):281-288. PubMed ID: 29718545
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
38. Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study.
Sartore G; Chilelli NC; Seraglia R; Ragazzi E; Marin R; Roverso M; Cosma C; Vaccaro O; Burlina S; Lapolla A
Acta Diabetol; 2019 May; 56(5):505-513. PubMed ID: 30740640
[TBL] [Abstract][Full Text] [Related]
39. Advanced glycation end products are associated with sarcopenia in older women: aging marker dynamics.
Eguchi Y; Toyoguchi T; Inage K; Fujimoto K; Orita S; Suzuki M; Kanamoto H; Abe K; Norimoto M; Umimura T; Koda M; Furuya T; Aoki Y; Nakamura J; Akazawa T; Takahashi K; Ohtori S
J Women Aging; 2021; 33(3):328-340. PubMed ID: 31770087
[TBL] [Abstract][Full Text] [Related]
40. Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus.
Jiménez IU; Díaz-Díaz E; Castro JS; Ramos JP; León MC; Alvarado Ríos JA; Auriostigue Bautista JC; Correa-Rotter R; Aguilar Salinas CA; Larrea F
Arch Med Res; 2017 May; 48(4):360-369. PubMed ID: 29157674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
